Experts look ahead to advancement in vaccine booster approvals

Vaccine and data experts from Johns Hopkins on Friday helped to explain and give context to federal regulatory action and the COVID-19 pandemic. Experts at the Johns Hopkins Bloomberg School of Public Health and the Food and Drug Administration are wrestling with the same issues: making decisions based on imperfect data, and -- in the face of a severe pandemic -- how much evidence is really necessary?

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting